MARKET

IGC

IGC

IGC Pharma Inc
AMEX
0.2957
-0.0034
-1.14%
Opening 12:31 04/28 EDT
OPEN
0.2958
PREV CLOSE
0.2991
HIGH
0.3073
LOW
0.2950
VOLUME
71.81K
TURNOVER
--
52 WEEK HIGH
0.6330
52 WEEK LOW
0.2525
MARKET CAP
23.56M
P/E (TTM)
-2.3885
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at IGC last week (0421-0425)?
Weekly Report · 6h ago
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 3d ago
IGC Pharma announces strategic investment from advisors
TipRanks · 4d ago
Weekly Report: what happened at IGC last week (0414-0418)?
Weekly Report · 04/21 10:15
'Bipartisan Congressional Lawmakers File Bill To End Federal Marijuana Prohibition In Legal States In Line With Trump's Stance' - Marijuana Moment
Benzinga · 04/17 15:59
Weekly Report: what happened at IGC last week (0407-0411)?
Weekly Report · 04/14 10:09
IGC Pharma expands CALMA trial with addition of Butler Hospital Program
TipRanks · 04/08 13:35
Weekly Report: what happened at IGC last week (0331-0404)?
Weekly Report · 04/07 10:09
More
About IGC
More
IGC Pharma, Inc. is a clinical-stage company, which is engaged in developing treatments for Alzheimer’s disease. The Company’s flagship drug, IGC-AD1, is an investigational drug tackles agitation, a major burden for patients and caregivers by addressing neuroinflammation. The Company operates through two segments: Life Sciences Segment and Infrastructure Segment. Its TGR-63 has demonstrated its potential to disrupt the progression of Alzheimer’s by targeting Aβ plaques, a key disease hallmark. The Company’s IGC-1C represents a potential breakthrough by targeting tau protein and neurofibrillary tangles, aiming to modify the disease course. Its IGC-M3 focuses on early intervention by inhibiting Aβ plaque formation, potentially slowing cognitive decline. Its LMP is designed to target multiple hallmarks of Alzheimer’s disease, including Aβ plaques and neurofibrillary tangles for a comprehensive therapeutic effect. It seeks to leverage artificial intelligence (AI) for Alzheimer's research.
Recently
Symbol
Price
%Change
    IGC
  • 0.2957
  • -1.14%

Webull offers IGC Pharma Inc stock information, including AMEX: IGC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IGC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IGC stock methods without spending real money on the virtual paper trading platform.